Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols
- 15 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (3) , e465-e476
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosisJournal of Inherited Metabolic Disease, 2017
- Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosisJournal of Inherited Metabolic Disease, 2015
- A useful multi-analyte blood test for cerebrotendinous xanthomatosisClinical Biochemistry, 2014
- A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosisJournal of Inherited Metabolic Disease, 2014
- ESI-MS/MS quantification of 7α-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosisClinica Chimica Acta, 2010
- Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTXJournal of Inherited Metabolic Disease, 2008
- Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosisSteroids, 1995
- Detection of carriers of cerebrotendinous xanthomatosisClinica Chimica Acta, 1986
- Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein BMetabolism, 1983
- Cerebrotendinous XanthomatosisArchives of Neurology, 1968